Author: Abizar Attari
News Editor

Washington, D.C., October 9: The United States Department of Labor has officially suspended eight major technology and global IT services firms from participating in the Permanent Labor Certification (PERM) program, Vice President JD Vance announced on X. This action halts new permanent residency (green card) filings even as the administration continues to investigate systemic H-1B visa fraud and the alleged displacement of American tech workers. With this suspension, US tech companies Microsoft, Adobe and Indian IT majors Infosys, TCS, Wipro, HCL, Cognizant and Capgemini have been barred from filing new PERM applications, effectively scuttling their plans to hire qualified foreign…

On a hot, sunny day, after playing at the neighbourhood maidan, a group of young teenagers troops into a roadside joint to recharge themselves after a tiring day. This means having a light snack and, most importantly, a beverage to cool your body down. For them, choosing the right drink is also associated with boosting energy, as many of the cola brands are marketed. Subconsciously, they tend towards brands that promise an instant boost of energy, and that remains the core argument for Campa Cola, PepsiCo and Monster India against the Food Safety and Standards Authority of India (FSSAI)’s ban…

Indians are living in hope, hoping for returns from promises that are increasingly more dependent on hype than hope. This comes at a time when the stock market hasn’t delivered a positive return in two years, but domestic investors believing in India’s growth story nevertheless. “The broader market has been steadily falling. The numbers may not fully show it, but it certainly feels like a bear market. IPOs, on the other hand, are a full-on party. Most recent listings have done well, and you can see it in the rush of activity. I don’t remember the last time we saw…

New Delhi, October 7: The Union Cabinet has approved the establishment of the  Integrated Transport & Logistics Authority (ITLA) to plan, monitor and coordinate freight and transit networks across the country, PM Modi tweeted. The Cabinet has approved the setting up of the Integrated Transport & Logistics Authority (ITLA) to bring greater coordination, data-led planning and multimodal integration across India’s transport ecosystem. This will have a wide-ranging impact on our growth trajectory. https://t.co/6jvuQD8k9g — Narendra Modi (@narendramodi) October 6, 2026 Established as a Special Purpose Vehicle (SPV), the ITLA will be responsible for treamline logistics operations, eliminate inter-agency bottlenecks, and…

India is still just at 3.2% in the global manufacturing value addition, just from 1.5% since the Make In India initiative launched in 2014, according to a NITI Aayog report. Despite having the world’s largest population, India still trails China and other emerging economies in manufacturing capabilities.  Despite its flaws, the Make In India initiative has helped accelerate industrial growth. It started with low margin assembly, but moved towards self sufficiency and to serve global demand through a distributed supply chain. Here are four sectors that have defined this shift, and what they are aiming to do to address it. …

Mumbai, October 2: Leading aluminium producer Hindalco Industries has mutually agreed to call off its proposed $125 million acquisition of US based AluChem Companies due to extended delays that both companies could not control. The transaction has been formally terminated on October 1, 2026 the company said in a regulatory disclosure.  The acquisition was originally announced in June 2025 with a value of $125 million. This would have helped Hindalco boost its presence in the specialty alumina segment, offering it better margins. Over the 16-month period, both companies have encountered extensive delays and administrative bottlenecks, forcing them to terminate their…

Mumbai, October 2: Symbiotec Pharmalab’s shares surged nearly 6% after its wholly owned subsidiary, Knovea Pharmaceuticals, secured an exclusive partnership with a leading unnamed pharma firm to commercialise and distribute two of its injectable products in the United States.  Under the terms of the deal, Knovea Pharmaceuticals will retain full control over the product development, long term manufacturing and regulatory filings for the products while the global partner will be responsible for marketing, sales and commercial distribution across the US healthcare market.  This collaboration is aimed at delivering milestone payments to Knovea across key project phases, including product development, regulatory…

Mumbai, October 2: After more than a month of uncertainty, HDFC Bank has named Anup Bagchi, a veteran from ICICI Bank Group, as its next Managing Director and CEO. The Reserve Bank of India (RBI) approved his three-year term starting October 27, 2026. He will take over from Sashidhar Jagdishan, who decided not to seek another term. ​ Following the central bank’s nod, HDFC Bank’s board has approved Bagchi’s appointment, effective October 2, for a three-year term. For HDFC Bank’s investors, this appointment is positive news, as the delay in appointing the CEO was affecting the bank’s standing on the…

Mumbai, October 1:  Leading Indian equity indices, the BSE Sensex and NSE Nifty 50 have recorded their eighth consecutive week of losses, with the Sensex falling 570 points to reach 71,909 while the Nifty fell 198.50 points, as the markets have witnessed one of the sharpest declines in recent years.  – Market falls for 8 consecutive weeks, the first time in 25 years. – Nifty slipped over 3 per cent this week, worst weekly fall in 6 months – Barring IT, all indices record losses @Nigel__DSouza wraps up the market this week pic.twitter.com/1FEPWQwaax — CNBC-TV18 (@CNBCTV18News) October 1, 2026 This…

Hyderabad, October 1: Indian pharmaceutical major Gland Pharma Limited has announced a $21 million (approximately ₹175 crore) investment in its US subsidiary to acquire a 60% controlling stake in the newly incorporated Novelstar Pharma Inc. The transaction is aimed at expanding Gland Pharma’s presence and market reach in the United States. According to a regulatory filing made today, the company’s Board of Dirctors has approved a capital infusion of $21 million into Gland Pharma USA, its step-down subsidiary. Gland Pharma USA Inc. will use the cash investment to buy 60% of the equity share capital of Novelstar Pharma Inc. The…